Endogaeic ground beetles fauna in oilseed rape field in Croatia

The abundance of ground beetles (Coleoptera, Carabidae) in oilseed rape field can be an important indicator of different agricultural measures in arable land fauna. Surveys about ground beetle fauna in Croatia are generally very scarce and only few research on oilseed rape were conducted. The aim of this study was to determine the endogaeic ground beetle fauna in oilseed rape field and to determine species abundance and frequency. The study was carried out in Podravina region of Croatia, from the end of May till the mid-September in 2015. Ground beetles were collected using endogaeic traps incorporated in the soil. Altogether, 487 individuals classified into 8 species were collected. Species with the highest abundance and frequency was Brachinus (Brachinus) psophia Audinet-Serville, 1821, which was classified as eudominant and constant species. The highest ground beetle abundance was observed in summer period. All of the species found were spring breeders, except for species Trechus (Trechus) quadristriatus (Schrank, 1781) which breeds in autumn

Znanstveno-stručni skupovi

4. hrvatski simpozij o invazivnim vrstama III. međunarodni znanstveno-stručni skup Inovacije i agrobiznis: Kružna ekonomija i održivost XI. Kongres o korovima i savjetovanje o herbicidima i regulatorima rast

Znanstveno-stručni skupovi

4. hrvatski simpozij o invazivnim vrstama III. međunarodni znanstveno-stručni skup Inovacije i agrobiznis: Kružna ekonomija i održivost XI. Kongres o korovima i savjetovanje o herbicidima i regulatorima rast

Effectiveness and Pharmacokinetic evaluation of Geonistin® (Oxytetracyline and Nystatin) Vaginal Tablets for Unspecific and Mixed Vulvovaginal Infections (GENIE Study)

The GENIE study was performed to evaluate the effectiveness and systemic exposure to oxytetracycline in local treatment of unspecific and mixed vulvovaginal infections characterized by vaginal discharge with Geonistin® vaginal tablets (100 mg oxytetracycline and 100 000 IU nystatin). The total number of subjects enrolled was 189. The treatment had beneficial effects in 100% of the study population. According to the Nugent score, the treatment had a positive effect in 89.2% of participants. The microbiological cure rate was 78.8%. Oxytetracycline concentration levels were from 13.3 to 32.2 ng/mL in 11 out of 15 subjects, and in four subjects the levels were below 10 ng/mL. Geonistin® had a beneficial effect on the unspecific and mixed vulvovaginal infections characterized by vaginal discharge in all efficacy and safety outcomes. Microbiological and the Nugent score efficacy measures confirmed clinical effectiveness. Beneficial efficacy results were achieved with only a few non-serious adverse events

Symptoms and Quality of Life in Patients with BPH

Benigna hiperplazija prostate (BPH) kronična je i progresivna bolest čija prevalencija raste s dobi i jako narušava kvalitetu života. Povećanje prostate i posljedični pritisak na mokraćnu cijev dovode do pojave simptoma BPH. Danas simptome BPH promatramo kao širu skupinu koju nazivamo simptomi donjeg urinarnog trakta (LUTS). Više od 40% pregleda u općoj urološkoj ambulanti vezano je uz tegobe donjeg urinarnog trakta. Ovo nas je potaknulo da provedemo presječno anketno istraživanje epidemiologije, dijagnostike i liječenja BPH u Republici Hrvatskoj. U istraživanje su uključena 1364 bolesnika i 50 urologa. Prosječna dob bolesnika bila je 67,0 godina. Od ukupno anketiranih bolesnika 646 odnosno 49,2% bilo je prvi put kod urologa. U ovom radu prikazani su rezultati i analiza ove ankete.Benign prostatic hyperplasia (BPH) is a chronic and progressive disease whose prevalence increases with age and seriously impairs the quality of life. Enlargement of the prostate and the consequent pressure on the urethra leads to the onset of BPH symptoms. Today we look at the symptoms of BPH through a wider group that is called lower urinary tract symptoms (LUTS). Over 40% of visits to general urological outpatient clinic are associated with lower urinary tract symptoms. This inspired us to perform the cross-sectional survey of the epidemiology, diagnosis and treatment of BPH in the Republic of Croatia. The study included 1364 patients and 50 urologists. The average patient age was 67.0 years. Of all the surveyed patients 646 or 49.2% were for the first time seen by the urologist. This paper presents the results and analysis of this survey

Moths of Economic Importance in the Maize and Sugar Beet Production

Maize and sugar beet productions are often threatened by various pests, causing high yield losses. Economically, most important maize pest is European corn borer, while sugar beet moth and noctuid moths cause serious damage on the sugar beet. This chapter highlights an introduction to several case studies representing long-term field research results on these pests. Depending on the pest, each study investigated the population level, dynamics of emergence or flight, damage levels and possibilities of forecasting on different localities in Croatia. The results could be of great importance in management of these pests. The European corn borer management depends mainly on timely conducted control, but the damage level also depends on maize hybrid and climatic conditions of investigated area. Damages caused by sugar beet moth depend on the population level and on locality’s specific climate in a particular year. Sugar beet moth population and flight dynamics can be monitored by using pheromones, while pheromone application in forecasting and control showed to be disputable. Noctuid moths feed on the sugar beet foliage, causing high damages, especially on young plants. The damage level depends on the climatic conditions of the research area, and visual inspections of caterpillars are necessary for forecasting and control decision

Sigurnost i djelotvornost azitromicina u liječenju infekcija donjih dišnih putova: međunarodna multicentrična ne-usporedna studija

The aim of this study was to describe clinical effectiveness of azithromycin in the management of lower respiratory tract infections in daily clinical practice, to examine duration of symptoms after therapy initiation, and to record any possible adverse effects of azithromycin treatment. A total of 153 patients were included in the analysis of the effectiveness of azithromycin: 94 patients with community acquired pneumonia (CAP) and 59 with acute exacerbation of chronic bronchitis (AECB). Clinical effectiveness was assessed as improvement, cure or failure after three-day treatment with azithromycin. The assessment was based on a calculation of clinical score for each diagnosis before treatment and on days 4, 10 and 28 after treatment initiation. Clinical effectiveness of azithromycin was 93.6% in CAP group and 94.9% in AECB group. Azithromycin led to relief of symptoms within three days in 88.6% of CAP patients and 77.2% of AECB patients. Overall, 15 adverse events were reported in 14 (9.1%) patients. The most common adverse events were abdominal pain, diarrhea and vomiting, each reported in four (2.6%) patients. Accordingly, azithromycin was found to have high clinical effectiveness and a small number of adverse events in the treatment of lower respiratory tract infections. ISRCTN38391551.Ciljevi ove studije bili su opisati kliničku djelotvornost azitromicina u liječenju infekcija donjih dišnih putova u kliničkoj praksi, ispitati trajanje simptoma nakon početka terapije te prikupiti podatke o neželjenim događajima. Uispitivanje su bila uključena 153 bolesnika: 94 bolesnika s pneumonijom iz opće populacije te 59 bolesnika s akutnom egzacerbacijom kroničnog bronhitisa. Klinička djelotvornost je ocijenjena kao poboljšanje, izlječenje ili neuspjeh liječenja trodnevnom terapijom azitromicinom. Procjena se osnivala na izračunu kliničkog indeksa za svaku dijagnozu prije početka terapije te nakon 4, 10 i 28 dana. Uovom ispitivanju klinička djelotvornost azitromicina bila je 93,6% u skupini bolesnika s pneumonijom iz opće populacije te 94,9% u bolesnika s akutnom egzacerbacijom kroničnog bronhitisa. Azitromicin je doveo do olakšanja simptoma unutar 3 dana kod 88,6% bolesnika s pneumonijom i 77,2% bolesnika s akutnom egzacerbacijom kroničnog bronhitisa. Zabilježeno je 15 neželjenih događaja kod 14 (9,1%) bolesnika. Najčešći neželjeni događaji su bili dijareja i povraćanje, od kojih je svaki zabilježen u 4 (2,6%) bolesnika. Rezultati ispitivanja pokazuju da azitromicin ima visoku djelotvornost u liječenju infekcija donjih dišnih putova i izaziva mali broj nuspojava. ISRCTN38391551